BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL AND Treatment
7 results:

  • 1. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. lncRNA ezr‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura--use of pulsed dye laser, copper vapor laser, and argon laser.
    Haedersdal M
    Acta Derm Venereol Suppl (Stockh); 1999; 207():1-32. PubMed ID: 10605602
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Copper vapour laser (578 nm) and flashlamp-pumped pulsed tunable dye laser (585 nm) treatment of port wine stains: results of a comparative study using test sites.
    Sheehan-Dare RA; Cotterill JA
    Br J Dermatol; 1994 Apr; 130(4):478-82. PubMed ID: 8186113
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Copper vapour laser treatment of port wine stains: clinical evaluation and comparison with conventional argon laser therapy.
    Sheehan-Dare RA; Cotterill JA
    Br J Dermatol; 1993 May; 128(5):546-9. PubMed ID: 8504047
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Results and tissue healing after copper-vapour laser (at 578 nm) treatment of port wine stains and facial telangiectasias.
    Neumann RA; Leonhartsberger H; Böhler-Sommeregger K; Knobler R; Kokoschka EM; Hönigsmann H
    Br J Dermatol; 1993 Mar; 128(3):306-12. PubMed ID: 8471515
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative histochemistry of port-wine stains after copper vapor laser (578 nm) and argon laser treatment.
    Neumann RA; Knobler RM; Leonhartsberger H; Gebhart W
    J Invest Dermatol; 1992 Aug; 99(2):160-7. PubMed ID: 1629627
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.